What Is a Huber Needle and How Does It Work?

A Huber needle is a specialized hollow needle with a bent, deflected tip designed to pierce the silicone septum of an implanted port without cutting out a tiny core of material. That non-coring property is the whole reason the needle exists: it lets healthcare providers access a port hundreds of times over months or years without destroying the rubber membrane that seals it. If you or someone you know has a port for chemotherapy, long-term antibiotics, or repeated blood draws, the Huber needle is the small but critical piece of hardware that makes the port usable over and over again.

How a Huber Needle Differs From a Standard Needle

A regular hypodermic needle has a beveled tip that slices straight through tissue and rubber. When it punches through the silicone septum of a port, that sharp bevel cuts out a microscopic cylinder of material, much like a hole punch cuts through paper. Over dozens of punctures, those tiny cores add up, gradually degrading the septum until it can no longer reseal properly. Leaking drugs or fluids into the surrounding tissue is the nightmare scenario, especially with caustic medications like certain chemotherapy agents.

The Huber needle solves this with a simple geometric change. Its tip is bent at a roughly 90-degree angle, creating a deflected point that parts the silicone fibers rather than slicing through them. Think of the difference between pushing a finger through a knit fabric, spreading the threads apart, versus cutting the threads with scissors. When you withdraw the Huber needle, the silicone fibers spring back together and the septum reseals. This is why Huber needles are also called “non-coring” needles, a term you will see used interchangeably in clinical settings.

The needle itself is typically attached to a short length of tubing that connects to an infusion line. Many designs include a flat “butterfly” wing on either side of the needle hub, giving the clinician something to grip during insertion and providing a stable base that can be taped to the patient’s skin. The wings keep the needle from rocking or shifting during long infusions, which can last hours.

What It Connects To

A Huber needle is useless on its own. It is designed exclusively for totally implantable venous access devices, commonly called ports or port-a-caths. A port is a small disc-shaped reservoir, usually titanium or plastic, surgically placed under the skin of the chest or upper arm. A thin catheter runs from the port into a large central vein, typically ending near the junction of the superior vena cava and the right atrium of the heart. The port’s top surface is covered by that silicone septum, and the whole device sits beneath the skin with no external parts visible.

To use the port, a clinician feels for the raised edges of the device through the skin, cleans the area, and pushes the Huber needle through the skin and into the septum. Once seated, the needle creates an open channel from the external tubing through the septum, into the port reservoir, down the catheter, and into the bloodstream. This allows infusion of medication, drawing of blood, or both. When the treatment session is over, the needle comes out, the septum reseals, and the patient walks away with no external hardware hanging from their body.

The type of implanted port matters for how straightforward the needle insertion is. Ports placed in the chest tend to sit on a firmer surface of underlying tissue than those implanted in the arm, and clinician experience plays a large role in getting the needle seated correctly on the first attempt.¹ For patients with deeper ports, more tissue between the skin surface and the septum, or unusual port orientations, the insertion can require more skill and sometimes imaging guidance.

Safety Features on Modern Huber Needles

One of the biggest occupational hazards in healthcare is needlestick injury, which can transmit bloodborne infections. Because a Huber needle is pulled from a port that has been infusing medications into a patient’s bloodstream, the tip is contaminated the moment it comes out. Modern Huber needles almost universally incorporate some type of safety-engineered protection mechanism to shield the tip the instant the clinician withdraws it.

These mechanisms vary by manufacturer. A study evaluating four commercially available designs found the following approaches in use:

Sliding sheath: A protective cover slides over the needle as the clinician pulls it out.
Spring-loaded closure: A button-activated spring snaps a protector closed over the needle tip after removal.
Blunt cannula swap: The sharp inner needle retracts into a housing, leaving only a blunt outer cannula behind, with a protection mechanism snapping into place during the process.
Push-over cover: A protective cap is manually pushed over the exposed needle during withdrawal.

Each of these designs aims to prevent the clinician’s fingers from ever being near the exposed needle tip after it leaves the patient’s skin.² The mechanisms differ in how intuitive they are to activate, how reliably they engage, and how well they work with ports that are deeply implanted. A safety feature that requires two hands to operate, for instance, is less practical than one that activates passively as the needle is withdrawn.

What It Feels Like for the Patient

The honest answer is that getting a Huber needle stuck through your skin and into a port is not painless, though many patients describe it as more of a firm pressure with a brief sharp sting than genuine severe pain. The skin over the port has normal nerve endings, and the needle has to push through several millimeters of tissue to reach the septum. For patients who access their port frequently, sometimes weekly for chemotherapy cycles, cumulative discomfort and anxiety can become a real quality-of-life issue.

Topical anesthetic creams are the standard tool for reducing insertion pain. The two most common options are EMLA cream, a mix of lidocaine and prilocaine, and tetracaine hydrochloride gel. A recent study measuring how long each cream needs to sit on the skin before rendering the needle stick painless found that tetracaine gel worked faster: about 39 minutes for half-maximal pain relief, with roughly 43 minutes needed for near-complete effectiveness. EMLA cream took longer, requiring about 56 minutes for half-maximal relief and around 64 minutes for the same level of near-complete numbness.³

The practical takeaway is that if you are headed to a clinic for a port access and want the numbing cream to actually work, you need to apply it well before your appointment, not in the waiting room. Many experienced port patients apply the cream at home under an occlusive dressing about an hour before arriving. If your clinic uses tetracaine rather than EMLA, you may be able to shave some time off that window, but cutting it much below 40 minutes risks feeling more of the stick than you would like.

Keeping the Port Working Between Uses

When a Huber needle is removed after an infusion, the port and its catheter are still sitting inside the body, filled with whatever fluid was last running through them. If that fluid sits stagnant, blood can backflow into the catheter tip and clot, blocking the line. To prevent this, clinicians flush the port and then lock it with a small volume of fluid designed to keep the catheter patent until the next use.

For years, heparin, a blood thinner, was the default locking solution for implanted ports. The assumption was that an anticoagulant was needed to prevent clotting inside the catheter. More recent evidence has challenged that assumption. A study comparing saline flushes to heparin locks found that saline was equally effective at maintaining port patency, with no increase in catheter occlusion rates when heparin was eliminated. The saline approach was also significantly cheaper.⁴ This matters for patients because heparin carries a small risk of side effects, including heparin-induced thrombocytopenia, a paradoxical condition where the anticoagulant actually triggers dangerous clotting. Switching to saline eliminates that risk entirely while keeping the port just as functional.

Not every institution has made the switch yet. If you have a port, it is worth asking your care team which locking solution they use and whether saline-only flushing is an option for your situation. Guidelines continue to evolve, and many cancer centers have already adopted saline-only protocols.

Why Ports Require a Huber Needle and Not Just Any Needle

This is a question patients sometimes ask, and the answer is not just “because the rules say so.” Using a standard hypodermic needle on an implanted port creates two problems. The first, septum coring, has already been covered: a regular needle chews up the silicone, eventually causing it to leak. The second problem is less obvious but equally important. When a standard needle cores out a tiny plug of silicone, that plug can be pushed into the port reservoir and from there potentially into the catheter and bloodstream. A silicone fragment traveling through a central vein is an embolism risk. It is a small fragment, but it is heading toward the heart and lungs, which is not where you want foreign debris.

Port manufacturers specify a maximum number of punctures their septum can withstand, often in the range of 1,000 to 2,000 when accessed with a proper Huber needle. Using a coring needle dramatically reduces that number. For a patient who may rely on the same port for years of treatment, preserving septum integrity is not a minor concern. It is the difference between keeping the device and needing surgery to replace it.

How Ports Compare to Other Long-Term IV Access

The main alternative to a port for long-term intravenous therapy is a peripherally inserted central catheter, commonly called a PICC line. A PICC is threaded through a vein in the arm up to the same central venous position, but unlike a port, a PICC has an external portion that sticks out of the skin. It requires regular dressing changes and flushes even when not in active use, and it limits activities like swimming. The trade-off is that placing a PICC does not require surgery, just a bedside procedure with local anesthesia.

A meta-analysis comparing the two approaches in cancer patients found that ports had a better safety profile overall, with lower rates of adverse effects, catheter-related blood clots, and allergic reactions compared to PICCs.⁵ An economic analysis also found that ports were more cost-effective than PICCs for treatment courses lasting six months or longer, with lower total costs when the full picture of maintenance, complications, and replacements was factored in.⁶ For shorter treatment courses of just a few weeks, PICCs may still make sense because they avoid the surgical step of port implantation.

From the patient’s perspective, the biggest day-to-day advantage of a port is cosmetic and lifestyle-related. Between treatment sessions, there is nothing visible on the body. You can shower normally, swim, and go about daily life without worrying about dressing changes or accidentally snagging an external line. The downside is that every time the port needs to be accessed, it requires a Huber needle stick through the skin, which is an experience PICC users avoid because their line is always externally available.

Ports and Newer Therapies

One concern that emerged with the rise of CAR T-cell therapy, a newer form of cancer treatment in which a patient’s own immune cells are engineered to attack cancer, was whether the angled Huber needle inside a port could damage the fragile modified cells as they were infused. The worry was that the deflected needle tip and the narrow passage through the port might create enough shear stress to harm or destroy the engineered T-cells. Because of this, many centers defaulted to PICC lines for CAR T-cell infusion.

A study comparing outcomes in patients who received CAR T-cell therapy through a port versus a PICC found no meaningful differences in safety or effectiveness. Response rates at 30 and 90 days were similar between the two groups, and there was no difference in how well the CAR T-cells expanded in the body after infusion. The port group actually had a lower rate of venous blood clots compared to the PICC group.⁷ The theoretical concern about the Huber needle damaging the cells did not hold up in practice. For patients who already have a port in place when they are referred for CAR T-cell therapy, this is reassuring: they may not need a second access device placed.

Needle Gauge and Length Selection

Huber needles come in a range of sizes, and choosing the right one depends on the clinical situation. Gauge refers to the needle’s diameter, with higher gauge numbers meaning thinner needles. A 22-gauge Huber needle is a common choice for standard infusions and blood draws. Thinner 20-gauge needles allow faster flow rates for viscous fluids like blood products or certain IV nutrition formulas, while smaller 24-gauge needles may be used when only medications are being delivered and lower flow rates are acceptable.

Length matters as well. A patient with very little tissue between the skin and the port may need a shorter needle, while someone with more subcutaneous tissue, whether from body habitus or post-surgical swelling, requires a longer one. Using a needle that is too short means the tip may not fully seat in the septum, leading to leakage or incomplete access. Too long, and the needle may bottom out against the back wall of the port reservoir, which can be uncomfortable and may interfere with flow. Clinicians typically palpate the port through the skin to estimate depth before selecting a needle length.

When Things Go Wrong

The most common Huber needle-related complication is dislodgement: the needle slips out of the septum while still connected to a running infusion. When this happens with a benign fluid like saline, it simply causes a wet dressing and a failed infusion. When it happens with a vesicant chemotherapy drug, one that damages tissue on contact, the drug can leak into the subcutaneous tissue surrounding the port. This is called extravasation, and it can cause serious local tissue injury including pain, blistering, and in severe cases necrosis.

Dislodgement is more likely when the needle is not securely taped down, when the patient moves significantly during the infusion, or when the selected needle length is marginal for the tissue depth. Some newer Huber needle sets incorporate stabilization platforms, adhesive bases that sit flat on the skin and distribute the holding force across a wider area rather than relying on tape alone. For patients receiving infusions over several days, such as continuous chemotherapy protocols, these stabilized designs reduce the risk of gradual needle migration.

Infection is another concern, though it is a risk of the port itself rather than the Huber needle specifically. Each time a needle punctures the skin, it creates a potential entry point for bacteria. Strict sterile technique during access, including thorough skin cleaning and use of sterile gloves, is the primary defense. Patients who self-access their ports at home are trained extensively in these protocols.

Accessing a Port at Home

Many patients with long-term ports eventually learn to access and de-access their own devices, particularly those receiving home infusion therapy for conditions like primary immune deficiency, cystic fibrosis, or certain chronic infections. The process follows the same sterile steps used in a clinical setting: hand hygiene, skin preparation with chlorhexidine, palpation of the port, and insertion of the Huber needle using a no-touch technique. Patients are also taught to flush and lock the port after use.

Self-access requires confidence and dexterity. Reaching the port on your own chest and pushing a needle through your own skin is psychologically and physically different from having a nurse do it. Training programs typically involve multiple supervised practice sessions before a patient is cleared to manage the procedure independently. For patients who manage it successfully, the payoff is substantial: fewer clinic visits, more flexibility in scheduling infusions, and a greater sense of control over their treatment. A family member or partner can also be trained as an alternative to self-access, which some patients find more comfortable, particularly for chest-placed ports that require using a mirror or working at an awkward angle.

Choosing the Right Huber Needle Set

If you are shopping for Huber needle supplies, either through a home health company or a pharmacy, the key variables are gauge, needle length, tubing length, and the type of safety mechanism. Most prescriptions will specify gauge and needle length based on the patient’s port and treatment plan. Tubing length is more of a practical preference: shorter tubing is easier to manage and tape down, while longer tubing gives more slack for movement during an infusion.

The safety mechanism deserves attention because not all designs work equally well for all patients. A spring-loaded retraction mechanism may be preferable for a patient who accesses their own port, since it automates the most dangerous step. A sliding sheath design may be simpler for a caregiver who is less experienced with needles and wants a more intuitive withdrawal process. If you have a choice, trying a sample of different brands during a supervised clinic visit is a practical way to find out which one feels most manageable before committing to a case of supplies for home use.